z-logo
Premium
Synthesis of Pyridotriazolopyrimidines as Antitumor Agents
Author(s) -
Abdallah Magda A.,
Gomha Sobhi M.,
Morad Mahmoud A.,
Elaasser Mahmoud M.
Publication year - 2017
Publication title -
journal of heterocyclic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.321
H-Index - 59
eISSN - 1943-5193
pISSN - 0022-152X
DOI - 10.1002/jhet.2699
Subject(s) - chemistry , pyrimidinones , triethyl orthoformate , hydrazone , ethyl chloroformate , anticancer drug , proton nmr , carbon 13 nmr , combinatorial chemistry , medicinal chemistry , cancer cell lines , stereochemistry , organic chemistry , drug , cancer cell , cancer , medicine , catalysis , psychology , psychiatry
2‐Hydrazino‐5,7‐di‐ p ‐tolylpyrido[2,3‐ d ]pyrimidin‐4(3 H )‐one ( 4 ) was prepared and condensed with different aldehydes 5a , 5b , 5c , 5d , 5e , 5f , 5g to give the corresponding hydrazone derivatives 6a , 6b , 6c , 6d , 6e , 6f , 6g . Oxidative cyclization of the latter compounds 6a , 6b , 6c , 6d , 6e , 6f , 6g gave the corresponding pyrido[2,3‐ d ][1,2,4]triazolo[4,3‐ a ]pyrimidin‐5(1 H )‐ones 7a , 7b , 7c , 7d , 7e , 7f , 7g . Furthermore, compound 4 reacted with benzoyl chloride, triethyl orthoformate, acetyl chloride , ethyl chloroformate, and carbon disulphide in alcoholic KOH solution to afford the corresponding pyrido[2,3‐ d ][1,2,4]triazolo[4,3‐ a ]pyrimidinones ( 7a , 8 , 9 , 10 , 11 ). The reaction of thione 3 or its 2‐methylthio derivative 16 with hydrazonoyl halides 12a , 12b , 12c , 12d , 12e , 12f , 12g , 12h , 12i , 12j , 12k , 12l , 12m yielded the corresponding pyrido[2,3‐ d ][1,2,4]triazolo[4,3‐ a ]pyrimidinones 15a , 15b , 15c , 15d , 15e , 15f , 15g , 15h , 15i , 15j , 15k , 15l , 15m . The structures of all the products were confirmed by elemental and spectral analyses ( 1 H NMR, 13 C NMR, IR, and MS). In addition, the anticancer activity of 20 pyridotriazolopyrimidinones against two cancer cell lines namely MCF‐7 and HepG2 was evaluated, and the results revealed that compounds 7d and 9 have promising activity , compared with doxorubicin, which used as standard reference drug.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom